Managed care

BELLUS Health Reports Year 2020 Financial Results and Business Highlights

Thursday, February 25, 2021 - 9:01pm

BELLUS Health is exploring how P2X3 activation can contribute to irritation and pain, and whether inhibition of P2X3 receptors can help treat these afferent hypersensitization-related disorders.

Key Points: 
  • BELLUS Health is exploring how P2X3 activation can contribute to irritation and pain, and whether inhibition of P2X3 receptors can help treat these afferent hypersensitization-related disorders.
  • BELLUS Health is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders.
  • Consequently, actual future results and events may differ materially from the anticipated results and events expressed in the forward-looking statements.
  • BELLUS Health believes that expectations represented by forward-looking statements are reasonable, yet there can be no assurance that such expectations will prove to be correct.

Humana Inc. to Present at the Barclays Global Healthcare Conference

Thursday, February 25, 2021 - 9:15pm

Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, President and Chief Executive Officer, will make a presentation to investors at the Barclays Healthcare Conference on Tuesday, March 9, 2021, at 8:00 a.m. Eastern time.

Key Points: 
  • Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, President and Chief Executive Officer, will make a presentation to investors at the Barclays Healthcare Conference on Tuesday, March 9, 2021, at 8:00 a.m. Eastern time.
  • A live audio webcast of the presentation will be available via Humanas Investor Relations page at humana.com .
  • Humana Inc. (NYSE: HUM) is committed to helping our millions of medical and specialty members achieve their best health.
  • More information regarding Humana is available to investors via the Investor Relations page of the companys web site at humana.com , including copies of:

Dr. Jeffrey N. Doucette, Distinguished Nurse Executive, Joins Press Ganey as Chief Nursing Officer

Thursday, February 25, 2021 - 8:02pm

Press Ganey today announced that Jeffrey N. Doucette, DNP, RN, NEA-BC, FACHE, FAAN, has joined the organization as Chief Nursing Officer.

Key Points: 
  • Press Ganey today announced that Jeffrey N. Doucette, DNP, RN, NEA-BC, FACHE, FAAN, has joined the organization as Chief Nursing Officer.
  • Nursing is the backbone of acute care in U.S. health systems, said Patrick T. Ryan, Chairman and Chief Executive Officer, Press Ganey.
  • Doucette, a widely recognized and accomplished nurse leader, comes to Press Ganey with nearly 30 years of experience spent largely in leadership and executive nursing roles.
  • Doucette will join Press Ganey as Chief Nursing Officer on April 26, 2021.

Mark Farrah Associates' 5500 Employer Health Plus Simplifies the Analysis of Employer Health and Welfare Benefit Plans

Thursday, February 25, 2021 - 7:35pm

This new tool has been designed to simplify the analysis of employer health & welfare benefits including medical, dental, vision, disability and other benefits.

Key Points: 
  • This new tool has been designed to simplify the analysis of employer health & welfare benefits including medical, dental, vision, disability and other benefits.
  • MFAs 5500 Employer Health Plus uniquely focuses on health & ancillary benefits purchased by private sector employers and the relationships employers have with contracted insurers, administrators and brokers.
  • Data sources include Form 5500 filings and related schedules for plans that have the indication of providing health & welfare benefits.
  • Committed to simplifying analysis of health insurance business, our products include: Health Coverage Portal , Medicare Business Online , Medicare Benefits Analyzer , County Health Coverage , Health Plans USA and 5500 Employer Health Plus .

Cannabis Testing Services Market 2020-2027: The Industry is Fragmented Based on service, End-Use, and Region - ResearchAndMarkets.com

Thursday, February 25, 2021 - 5:22pm

The "Cannabis Testing Services Market Share, Size, Trends, Industry Analysis Report, By Service Type; By End-Use; By Regions; Segment Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cannabis Testing Services Market Share, Size, Trends, Industry Analysis Report, By Service Type; By End-Use; By Regions; Segment Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.
  • The Cannabis Testing Service Market report gives a detailed insight into current market dynamics and provides analysis on future market growth.
  • The global cannabis testing service industry is fragmented based on service, end-use, and region.
  • The potency test segment is estimated to hold a major share in the global cannabis testing service industry, as the use of cannabis is rising in medicinal purposes.

Northwell Health-GoHealth Urgent Care Teams up With MSG Sports to Welcome Back Fans

Thursday, February 25, 2021 - 5:06pm

Northwell Health-GoHealth Urgent Care is working with MSG Sports to offer a convenient, trusted COVID-19 PCR testing solution for fans who have been welcomed back to Madison Square Garden.

Key Points: 
  • Northwell Health-GoHealth Urgent Care is working with MSG Sports to offer a convenient, trusted COVID-19 PCR testing solution for fans who have been welcomed back to Madison Square Garden.
  • Thats why MSG Sports has teamed up with Northwell Health-GoHealth Urgent Care to provide PCR testing so fans can safely return to The Garden and enjoy a truly New York experience.
  • We are proud to support MSG Sports as it welcomes fans back to Madison Square Garden, said Susan Bortone, senior director of operations at Northwell Health-GoHealth Urgent Care.
  • GoHealth Urgent Care is one of the countrys fastest-growing, largest and most technology-forward urgent care companies.

Optime Care Recognizes Rare Disease Day, February 28, 2021: Patient-First Strategy Maximizes Therapeutic Treatment for People with Orphan and Rare Disorders

Thursday, February 25, 2021 - 4:56pm

Optime Care , a nationally recognized pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, is pleased to join national and international efforts to raise awareness about rare diseases and their impact on patients' lives this Rare Disease Day , February 28.

Key Points: 
  • Optime Care , a nationally recognized pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, is pleased to join national and international efforts to raise awareness about rare diseases and their impact on patients' lives this Rare Disease Day , February 28.
  • Optime Cares patient-first approach provides comprehensive, best-in-class services tailored to maximize therapeutic opportunities for people in the rare disease community, including counseling, guidance and education based upon patient and caregiver needs.
  • Putting the patient first, the Optime Care approach streamlines patient enrollment, maximizes interaction with patients for adherence and compliance, and provides continuity of care to avoid lapses in therapy key components of high-quality care, especially during the COVID-19 pandemic, says Donovan Quill, president and CEO, Optime Care.
  • Our experience with small patient populations makes us uniquely qualified to help every stakeholder group impacted by these disorders.

Humana Military Names Alefiyah Mesiwala, M.D., Chief Medical Officer

Thursday, February 25, 2021 - 4:00pm

Humana Military, a wholly owned subsidiary of Humana Inc. (NYSE: HUM), announced today the appointment of Alefiyah Mesiwala, M.D., MPH, as Humana Militarys new Chief Medical Officer.

Key Points: 
  • Humana Military, a wholly owned subsidiary of Humana Inc. (NYSE: HUM), announced today the appointment of Alefiyah Mesiwala, M.D., MPH, as Humana Militarys new Chief Medical Officer.
  • Effective March 15, Dr. Mesiwala will serve as a member of the Humana Military leadership team and report to Brent Densford, President, Humana Government Business, Inc. Humana Military.
  • Humana Military is excited to have Dr. Mesiwala join our team and strengthen our partnership with the DHA.
  • As the Chief Medical Officer for Humana Military, Dr. Mesiwala will provide strategic leadership and direction for medical management and clinical operations of the TRICARE contract to ensure the delivery of high quality integrated health care.

Acadia Healthcare to Participate in Raymond James 42nd Annual Institutional Investors Conference

Thursday, February 25, 2021 - 4:00pm

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the Raymond James 42nd Annual Institutional Investors Conference, which is being held as a virtual event from March 1 - March 3, 2021.

Key Points: 
  • Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the Raymond James 42nd Annual Institutional Investors Conference, which is being held as a virtual event from March 1 - March 3, 2021.
  • The live webcast of the presentation will be available on the Companys website, www.acadiahealthcare.com , by clicking on the Investors link.
  • Acadia is a leading provider of behavioral healthcare services across the United States.
  • Acadia operates a network of 227 behavioral healthcare facilities with approximately 9,900 beds in 40 states and Puerto Rico.

SpectraMedix and InfoMC Partner to Deliver an Integrated Solution for Medicare Advantage Plans

Thursday, February 25, 2021 - 3:00pm

"This partnership provides an end-to-end solution tailored to the evolving needs of Medicare Advantage plans and their participating providers."

Key Points: 
  • "This partnership provides an end-to-end solution tailored to the evolving needs of Medicare Advantage plans and their participating providers."
  • Bringing our solutions together creates the perfect blend of actionable analytics and whole-person care management tools to help Medicare Advantage plans gain holistic population insights, close gaps and promote a higher standard of care," added JJ Farook, CEO of InfoMC.
  • The SpectraMedix Medicare Advantage Accelerator provides powerful, actionable analytics, insights, and real-time incentives that drive accurate RAF scores and better STAR ratings.
  • It seamlessly integrates with InfoMC's Incedo care management and population health solution to deliver a new level of actionable intelligence that drives performance improvement.